v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 15,064 $ 11,915 $ 39,382 $ 37,540
General and administrative 4,287 3,586 12,483 11,285
Total operating expenses 19,351 15,501 51,865 48,825
Loss from operations (19,351) (15,501) (51,865) (48,825)
Other income:        
Interest income 1,505 804 3,516 2,813
Interest and other expense 0 (2) 0 (2)
Total other income 1,505 802 3,516 2,811
Net loss (17,846) (14,699) (48,349) (46,014)
Other comprehensive loss:        
Unrealized loss on available-for-sale securities, net (17) 0 (30) 0
Total Comprehensive loss $ (17,863) $ (14,699) $ (48,379) $ (46,014)
Net loss per share attributable to common stockholders, basic $ (0.36) $ (1.09) $ (1.27) $ (3.41)
Net loss per share attributable to common stockholders, diluted $ (0.36) $ (1.09) $ (1.27) $ (3.41)
Weighted average shares outstanding: basic 49,928,151 13,530,892 37,956,765 13,488,493
Weighted average shares outstanding: diluted 49,928,151 13,530,892 37,956,765 13,488,493